OCULAR THERAPEUTIX, INC (OCUL) Share-based Payment Arrangement, Expense USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ocular Therapeutix, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2024.
  • Ocular Therapeutix, Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $7.98 M, a 74.5% increase year-over-year.
  • Ocular Therapeutix, Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $21.2 M, a 22.5% increase year-over-year.
  • Ocular Therapeutix, Inc annual Share-based Payment Arrangement, Expense for 2023 was $17.8 M, a 5.08% increase from 2022.
  • Ocular Therapeutix, Inc annual Share-based Payment Arrangement, Expense for 2022 was $17 M, a 13.3% increase from 2021.
  • Ocular Therapeutix, Inc annual Share-based Payment Arrangement, Expense for 2021 was $15 M, a 98.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $21.2 M $7.98 M +$3.41 M +74.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $17.8 M $4.33 M +$94 K +2.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $17.7 M $4.51 M +$272 K +6.42% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $17.5 M $4.41 M +$132 K +3.08% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $17.3 M $4.57 M +$363 K +8.62% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $17 M $4.23 M +$392 K +10.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $16.6 M $4.24 M +$482 K +12.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $16.1 M $4.28 M -$11 K -0.26% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $16.1 M $4.21 M +$1.12 M +36.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $15 M $3.84 M +$1.74 M +82.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 $13.2 M $3.76 M +$1.82 M +94.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $11.4 M $4.29 M +$2.47 M +135% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $8.95 M $3.09 M +$1.42 M +85.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $7.53 M $2.1 M +$151 K +7.73% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $7.38 M $1.94 M -$1.23 M -38.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $8.61 M $1.83 M +$131 K +7.73% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $8.48 M $1.67 M -$277 K -14.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $8.76 M $1.95 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $3.17 M +$1.3 M +69.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.7 M -$135 K -7.38% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1.94 M +$111 K +6.06% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 $1.87 M +$122 K +6.97% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.83 M +$73 K +4.16% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.83 M +$126 K +7.39% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $1.75 M +$382 K +27.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $1.76 M +$242 K +16% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.71 M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q3 2016 $1.37 M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $1.52 M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q3 2014 $607 K +$486 K +402% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $557 K +$436 K +360% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-29
Q3 2013 $121 K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $121 K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.